Q1 2025 saw sharply lower sales and increased losses due to delayed launches and high inventories, but HealthCare and AirCare segments showed strong momentum. Capital raise improved liquidity, and management expects sales recovery in H2 2025.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.